Fibroblast growth factor 23 (FGF23) Intact
Fibroblast growth factor is involved in phosphate metabolism. Over-expression leads to phosphate excretion. High levels are found in hypophosphataemic rickets. Clinical indication for request: a marker for the phosphate-wasting condition oncogenic osteomalacia and also hypophosphataemic rickets.
|Tube||04 (EP) - EDTA Plasma|
|Additional Information||Fasting sample required. Patient must not be ferritin deficient. Sample should be sent to the lab within one hour of collection.
FGF23 C-terminal is the front line test for FGF23, see separate entry. Intact FGF23 is preferred in patients who have reduced renal function (CKD stage 3+).
|Turn Around||Turnaround time stated by Norfolk & Norwich: 4 weeks.|
|Send to||Blood Sciences LGI
(Test referred to: Norfolk & Norwich University Hospital.)
|Advice||Full information on all referred tests can be found on the referred tests information database, EQMS reference BSF2REC17003.|
|Collection Con||Instructions to lab: Centrifuge, separate and freeze plasma within 1h of sample collection.
Minimum volume: 0.6mL.
|Ref. Range Notes||33-110 pg/mL|
|Telepath||LGI superset code FGFI, SJUH superset code JFGFI|